Growth hormone stimulates bone healing in a critical-sized bone defect model

Clinical Orthopaedics and Related Research

Volumn 446, Issue , 2006, Pages 259-267

  Theyse, L F H ^a   Oosterlaken Dijksterhuis, M A ^a   Doorn, J Van ^b   Dhert, W J A ^c   Hazewinkel, H A W ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DENSITOMETRY; BONE REGENERATION; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; FRACTURE HEALING; IMAGE ANALYSIS; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; RADIOGRAPHY; TREATMENT OUTCOME; ULNA FRACTURE;

ANIMALS; BONE REGENERATION; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GROWTH HORMONE; MALE; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS; TREATMENT OUTCOME; ULNA FRACTURES;

EID: 33744773475     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000203490.21206.7f     Document Type: Article

References (45)

1. Ascacio-Martinez JA, Barrera-Saldana HA. A dog growth hormone cDNA codes for a mature protein identical to pig growth hormone. Gene. 1994;143:277-280.
2. Bail HJ, Kolbeck S, Krummrey G, Schmidmaier G, Haas NP, Raschke MJ. Systemic application of growth hormone for enhancement of secondary and intramembranous fracture healing. Horm Res. 2002;58(suppl 3):39-42.
3. Bail HJ, Kolbeck S, Lindner T, Dahne M, Weiler A, Windhagen HJ, Raun K, Skjaerbaek C, Flyvbjerg A, Orskov H, Haas NP, Raschke MJ. The effect of growth hormone on insulin-like growth factor I and bone metabolism in distraction osteogenesis. Growth Horm IGF Res. 2001;11:314-323.
4. Bautista CM, Mohan S, Baylink DJ. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism. 1990;39:96-100.
5. Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair. Int J Dev Biol. 1993;37:573-579.
6. Conzemius MG, Brown DC, Brabec M, Smith GK, Washabau R, LaFond E, Chakraborty PK. Correlation between longitudinal bone growth, growth hormone, and insulin-like growth factor-I in prepubertal dogs. Am J Vet Res. 1998;59:1608-1612.
7. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res. 1994;301:302-312.
8. Drake WM, Carroll PV, Savage MO, Monson JP. Skeletal consequences of discontinuation of growth hormone at final height. J Pediatr Endocrinol Metab. 2002;15(suppl 5):1351-1354.
9. Dubreuil P, Abribat T, Broxup B, Brazeau P. Long-term growth hormone-releasing factor administration on growth hormone, insulin-like growth factor-I concentrations, and bone healing in the Beagle. Can J Vet Res. 1996;60:7-13.
10. Durham SK, Riggs BL, Conover CA. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J Clin Endocrinol Metab. 1994;79:1752-1758.
11. Edwall D, Prisell PT, Levinovitz A, Jennische E, Norstedt G. Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: influence of indomethacin. J Bone Miner Res. 1992;7:207-213.
12. Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosen T. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab. 2003;88:394-401.
13. Eigenmann JE, Eigenmann RY. Radioimmunoassay of canine growth hormone. Acta Endocrinol (Copenh). 1981;98:514-520.
14. Favier RP, Mol JA, Kooistra HS, Rijnberk A. Large body size in the dog is associated with transient GH excess at a young age. J Endocrinol. 2001;170:479-484.
15. Fukuda S, Iida H. Effects of orchidectomy on bone metabolism in beagle dogs. J Vet Med Sci. 2000;62:69-73.
16. Geusens P, Schot LP, Nijs J, Dequeker J. Calcium-deficient diet in ovariectomized dogs limits the effects of 17 beta-estradiol and nandrolone decanoate on bone. J Bone Miner Res. 1991;6:791-797.
17. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res. 2002;17:1408-1419.
18. Goodman SB, Song Y, Yoo JY, Fox N, Trindade MC, Kajiyama G, Ma T, Regula D, Brown J, Smith RL. Local infusion of FGF-2 enhances bone ingrowth in rabbit chambers in the presence of polyethylene particles. J Biomed Mater Res A. 2003;65:454-461.
19. Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone. 1995;17:93S-98S.
20. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg. 1991;73:750-764.
21. Hedner E, Linde A, Nilsson A. Systemically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes: an experimental study in rats. J Bone Miner Res. 1996;11:1952-1960.
22. Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology. 1995;136:124-131.
23. Hill PA, Tumber A, Meikle MC. Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology. 1997;138:3849-3858.
24. Jaffe CA, Turgeon DK, Lown K, Demott-Friberg R, Watkins PB. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab. 2002;283:1008-1015.
25. Kassem M, Brixen K, Mosekilde L, Blum WF, Flyvbjerg A. Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women. Clin Endocrinol (Oxf). 1998;49:747-756.
26. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 1996;28:619-637.
27. Kelly PA, Finidori J, Moulin S, Kedzia C, Binart N. Growth hormone receptor signalling and actions in bone growth. Horm Res. 2001;55(suppl 2):14-17.
28. Kirpensteijn J, Timmermans-Sprang EP, van Garderen E, Rutteman GR, Lantinga-van Leeuwen IS, Mol JA. Growth hormone gene expression in canine normal growth plates and spontaneous osteosarcoma. Mol Cell Endocrinol. 2002;197:179-185.
29. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone. 1996;19:1-12.
30. Mohan S. Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul. 1993;3:67-70.
31. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology. 2003;144:929-936.
32. Nap RC, Mol JA, Hazewinkel HA. Age-related plasma concentrations of growth hormone (GH) and insulin- like growth factor I(IGF-I) in Great Dane pups fed different dietary levels of protein. Domest Anim Endocrinol. 1993;10:237-247.
33. Raschke MJ, Bail H, Windhagen HJ, Kolbeck SF, Weiler A, Raun K, Kappelgard A, Skiaerbaek C, Haas NP. Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. Bone. 1999;24:81-88.
34. Schmidmaier G, Wildemann B, Heeger J, Gabelein T, Flyvbjerg A, Bail HJ, Raschke M. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1. Bone. 2002;31:165-172.
35. Sjogren K, Jansson JO, Isaksson OG, Ohlsson C. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine. 2002;19:249-256.
36. Sota de la RL. Simmen FA, Diaz T, Thatcher WW. Insulin-like growth factor system in bovine first-wave dominant and subordinate follicles. Biol Reprod. 1996;55:803-812.
37. Srinivasan N, Edwall D, Linkhart TA, Baylink DJ, Mohan S. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. J Endocrinol. 1996;149:297-303.
38. Thoren M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Saaf M, Baylink DJ, Mohan S. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)- deficient adults and increase with GH replacement therapy. J Bone Miner Res. 1998;13:891-899.
39. Tiangco DA, Papakonstantinou KC, Mullinax KA, Terzis JK. IGF-I and end-to-side nerve repair: a dose-response study. J Reconstr Microsurg. 2001;17:247-256.
40. Tryfonidou MA, Holl MS, Vastenburg M, Oosterlaken-Dijksterhuis MA, Birkenhager-Frenkel DH, van den Brom WE, Hazewinkel HA. Hormonal regulation of calcium homeostasis in two breeds of dogs during growth at different rates. J Anim Sci. 2003;81:1568-1580.
41. van Doorn J, Cornelissen AJ, Buul-Offers SC. Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions. Clin Endocrinol (Oxf). 2001;54:655-664.
42. van Doorn J, Ringeling AM, Shmueli SS, Kuijpers MC, Hokken-Koelega AC, Buul-Offers SC, Jansen M. Circulating levels of human insulin-like growth factor binding protein- 6 (IGFBP-6) in health and disease as determined by radioimmunoassay. Clin Endocrinol (Oxf). 1999;50:601-609.
43. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, Li XJ. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res. 1998;13:1483-1490.
44. Wilkens BE, Millis DL, Daniel GB, Munson L, Patel KR, Buonomo FC. Metabolic and histologic effects of recombinant canine somatotropin on bone healing in dogs, using an unstable ostectomy gap model. Am J Vet Res. 1996;57:1395-1401.
45. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van Doorn J, Juul A. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin- like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal. 1999;13:166-172.